AllTrials will be a centrepiece of a new online course taught by the University of Miami called Health Information Exchange. Students of this course, aimed at nurses and medical professionals, will learn why clinical trial transparency is so important to researchers and physicians. This course is part of a new Online Health Informatics, Nursing Informatics and Certificate […]
Clinical trial transparency is a key priority of the new Executive Director of the European Medicines Agency (EMA), Professor Guido Rasi.
In a press briefing on Wednesday 9th December Professor Rasi outlined his vision for his five-year mandate as Executive Director. He highlighted transparency as a key aspect of the EMA’s approach moving forward.
On the EMA’s commitment to transparency, […]
To make every clinical trial count, changes to registration and reporting behaviour need to be global. Building support for AllTrials in the US is crucial.
The UK AllTrials video has helped tremendously to raise awareness and grow the campaign. Watch it again to see the impact it has. It captures clearly and powerfully why clinical trial transparency is […]
The largest association of medical doctors and students in the US, the American Medical Association (AMA)—which represents over 228,000 current healthcare providers—will decide in the coming weeks whether to publicly support AllTrials in the US. The move comes after the AMA passed a series of policy resolutions supporting increased data sharing and the timely publication […]
A new study published in BMJ Open found that for 15 drugs approved by the US Food and Drug Administration (FDA) in 2012, a median 57% of clinical trials were registered, and only 65% of trial results were publicly available. Almost half of the drugs had at least one undisclosed phase II or III trial. […]
Research published in BMC Medical Ethics has found that NHS research ethics committees (RECs) could monitor bias in clinical trial publication and outcome reporting. RECs review all applications for NHS research conducted in the UK and determine whether the research is ethical. There are currently more than 60 RECs across the UK that each year review […]
The number of clinical trials registered globally increased from 3,294 in 2004, to 23,384 in 2013, according to new research published in BMJ Open. The study looked at clinical trials on the World Health Organisation’s International Clinical Trials Registry Platform (ICTRP), which contains data from 16 global trial registries. The research analysed global progress in […]
This blog was originally published on The BMJ blogs site at bmj.com/blogs
Diclectin Data: Testing Canada’s New Pharmaceutical Transparency Law
Matthew Herder a & Trudo Lemmens b
Earlier this month Canadian news sources, including the CBC and the Toronto Star, reported on Dr. Navindra Persaud’s success in securing unpublished data from Health Canada about the safety and effectiveness […]
The results of around half of all clinical trials have never been published. Failing to publish results means the people who make decisions about medicines don’t have full information about the benefits and risks of treatments we use every day.
Use The Economist’s publication bias simulator to run clinical trials yourself, decide which trials to publish, and see how much […]
We are delighted that Simon Singh, science writer and Sense about Science trustee, is auctioning his Second World War cipher machine to raise money for the AllTrials campaign and Good Thinking.
The M-209 is a portable mechanical cipher machine (about the size of a lunchbox) that was used by the US military during WW2 and the […]